We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Probes Mental State In Dr. Reddy's Manufacturing Suit

Law360, Trenton (August 8, 2018, 9:37 PM EDT) -- A New Jersey federal judge expressed skepticism Wednesday over Dr. Reddy’s Laboratories Ltd.’s bid to toss a putative consolidated class action on the grounds that investors failed to adequately plead that the business intended to deceive them in making allegedly misleading statements about quality control issues at manufacturing facilities.

At a hearing on the pharmaceutical company’s motion to dismiss the amended suit, U.S. District Judge Peter G. Sheridan said the complaint gave rise to an inference that Dr. Reddy’s acted with that state of mind — known as scienter — in its alleged misrepresentations to investors.

“I generally thought just reading the complaint ... you can see scienter,”...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

New Jersey

Nature of Suit

Securities/Commodities

Judge

Subscribers Only

Date Filed

August 25, 2017

Law Firms

Companies

Government Agencies

Judge Analytics